Patents by Inventor Jerry L. Born

Jerry L. Born has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of radiotherapy using biomodulators
    Patent number: 6375927
    Abstract: Biomodulators, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radio-images, preferably by increasing aberrant tissue signal intensity. Biomodulators can also condition tissue to enhance up-take of otherwise non-specific imaging agents. When linked to drugs, biomodulators can target the same to particular sites in the body.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: April 23, 2002
    Inventors: Jerry L. Born, Dennis Eshima, Paul L. Mann, Nicholas A. Matwiyoff
  • Arsenic-72 labeled compounds for tissue specific medical imaging
    Patent number: 6106804
    Abstract: Radioactive arsenic (.sup.72 As) labelled tissue specific ligands are prepared and used in the medical imaging of malignant breast or prostate tumors.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: August 22, 2000
    Assignee: The University of New Mexico
    Inventors: Robert B. Palmer, Jerry L. Born
  • Biomodulators as universal imaging agents
    Patent number: 6033644
    Abstract: Biomodulators, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radio-images, preferably by increasing aberrant tissue signal intensity. Biomodulators can also condition tissue to enhance uptake of otherwise non-specific imaging agents. When linked to drugs, biomodulators can target the same to particular sites in the body.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: March 7, 2000
    Assignee: University of New Mexico
    Inventors: Jerry L. Born, Dennis Eshima, Paul L. Mann, Nicholas A. Matwiyoff
  • Arsenic-72 labeled compounds for tissue specific medical imaging
    Patent number: 5914096
    Abstract: Radioactive arsenic (.sup.72 As) labelled tissue specific ligands are prepared and used in the medical imaging of malignant breast or prostate tumors.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: June 22, 1999
    Assignee: University of New Mexico
    Inventors: Robert B. Palmer, Jerry L. Born
  • Method of MRI using biomodulators
    Patent number: 5906807
    Abstract: Biomodulators, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radio-images, preferably by increasing aberrant tissue signal intensity. Biomodulators can also condition tissue to enhance uptake of otherwise non-specific imaging agents. When linked to drugs, biomodulators can target the same to particular sites in the body.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: May 25, 1999
    Assignee: University of New Mexico
    Inventors: Jerry L. Born, Dennis Eshima, Paul L. Mann, Nicholas A. Matwiyoff
  • Biomodulators as universal imaging agents
    Patent number: 5401489
    Abstract: Biomodulators, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radio-images, preferably by increasing aberrant tissue signal intensity. Biomodulators can also condition tissue to enhance uptake of otherwise non-specific imaging agents. When linked to drugs, biomodulators can target the same to particular sites in the body.
    Type: Grant
    Filed: May 1, 1991
    Date of Patent: March 28, 1995
    Assignee: University of New Mexico
    Inventors: Jerry L. Born, Dennis Eshima, Paul L. Mann, Nicholas A. Matwiyoff
  • Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
    Patent number: 5399338
    Abstract: Biomodulators, in conjunction with antibodies, tumor-specific agents or conjugates thereof, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radioimages, preferably by increasing aberrant tissue signal intensity.
    Type: Grant
    Filed: May 1, 1991
    Date of Patent: March 21, 1995
    Assignee: University of New Mexico
    Inventors: Jerry L. Born, Dennis Eshima, Paul L. Mann, Nicholas A. Matwiyoff, Buck A. Rhodes
  • Image enhancement by coadministration of biomodulators and structurally modified imaging agents
    Patent number: 5240693
    Abstract: Biomodulators can be administered together with an agent such as a drug or an imaging agent (specific or non-specific) structurally modified to take advantage of perturbations of cell oligosaccharide displays caused by biomodulators, to enhance images of a host, e.g., NMR-, X-ray- or radioimages, preferably by increasing aberrant tissue signal intensity. Biomodulators condition tissue to enhance or otherwise modify up-take of the drug or structurally modified imaging agent.
    Type: Grant
    Filed: May 1, 1991
    Date of Patent: August 31, 1993
    Assignee: University of New Mexico
    Inventors: Jerry L. Born, Dennis Eshima, Frank O. Kroh, Paul L. Mann